RecruitingNot ApplicableNCT05781295

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in the Primary Prevention of Catheter-related Endoluminal Infection in Paediatric Oncology.

Sponsor

Institut Curie

Enrollment

148 participants

Start Date

Jan 19, 2024

Study Type

INTERVENTIONAL

Conditions

Oncology Children Primary Prevention MEDICAL DEVICE

Summary

Interest of a Taurolidine lock at each catheter closure in the primary prevention of catheter-related endoluminal infection in paediatric oncology. Multicentric, controlled, randomized and double-blind label study.

Eligibility

Max Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Physiological serum and a medical device called TaurolockTM for people with children, medical device, and other related conditions. The study is currently recruiting participants at 5 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETaurolockTM

The patient will be followed up to a maximum of 6 months after randomization after have a TaurolockTM injected each time catheter will be used.

DEVICEPhysiological serum

The patient will be followed up to a maximum of 6 months after randomization after have a Physiological serum injected each time catheter will be used.